22nd Century Group Reports Third Quarter 2026 Financial Results


Revenue Grew 66% to $4.8 Million; Gross Profit Turned Positive at $0.4 Million

MOCKSVILLE, N.C., Nov. 16, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the leader in low-nicotine tobacco, low-nicotine cigarettes and only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced results for the third quarter ended September 30, 2026, and provided an update on recent commercial, regulatory and operational activities.

“The third quarter marked a period of accelerating commercial execution featuring expanded market adoption of our Pinnacle branded products. We grew revenue 66% sequentially to $4.8 million, turned gross profit positive, and meaningfully reduced our operating loss, all while continuing to expand retail distribution, increase consumer awareness and strengthen the commercial foundation for our VLN® products," said Larry Firestone, Chief Executive Officer of 22nd Century Group. "Most notably, sales of Pinnacle® VLN® and Pinnacle Pure™ cigarette products measured at the cash register increased 166% compared to the second quarter. This is clear evidence that adult smokers that try our low nicotine Pinnacle VLN® cigarettes are including this product in their smoking practice. 70% of the U.S. $50 billion cigarette market has declared that they are looking for a solution that will allow them to change their smoking habits and address their nicotine cravings head on. We have that solution in our Pinnacle® VLN® and 22nd Century VLN® cigarettes in the most familiar form the smoker is accustomed to, a combustible cigarette with significantly reduced nicotine. The science is proven, and smokers are putting our VLN® products to the test."

“During the quarter, we broadened our retail footprint with shipments into approximately 150 additional stores across metro New York and northern New Jersey, expanded the Pinnacle Pure™ lineup to six SKUs across Yellow, Blue and Green styles in both King Size and 100's, secured state regulatory approvals in an additional 13 states, and recently announced a distribution partnership with Gopuff, a nationwide direct-to-consumer digital convenience platform, extending our market reach with VLN® cigarettes beyond brick-and-mortar retail and adding significant opportunities through their digital platform for consumer awareness for adult smokers."

"Alongside this commercial progress, we significantly cleaned up our capital structure. Following quarter-end, we raised $5.8 million of net cash proceeds through an at-the-market offering, used $1.2 million of those proceeds to redeem an equal amount of our Series B convertible preferred stock at par, and enter the fourth quarter with no warrants outstanding. We now have a simpler cap table that positions us to pursue growth capital in the future with significantly less overhang. With our proprietary technology, FDA-authorized products, increasing commercial distribution, a strengthened balance sheet, clean cap table and a scalable business model, we believe 22nd Century is well positioned to create long-term value for adult smokers seeking familiar alternatives while delivering value for our shareholders."

Third Quarter 2026 Financial Results (compared to Second Quarter 2026, except as noted)

All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of the Company’s hemp/cannabis business in late 2023, except as noted.

  • Net revenues increased to $4.8 million from $2.9 million.
  • Gross profit (loss) improved to $0.4 million, compared to $(0.3) million.
  • Operating expenses were $3.0 million, consistent with the second quarter of 2026.
  • Operating loss decreased to $2.6 million, compared to $3.3 million.
  • Net loss from continuing operations was $2.6 million, compared to a net loss of $3.3 million.
  • Adjusted EBITDA loss was $2.2 million, compared to a loss of $2.9 million.
  • Subsequent to quarter-end added $5.8 million of net cash proceeds from at-the-market offering, of which $1.2 million was used to redeem an equal amount of outstanding Series B convertible preferred shares at par.
  • No warrants to purchase shares of common stock remain outstanding as of September 30, 2026.

Recent Business Highlights

  • Recorded a 166% increase in point-of-sale (POS) pack sales in the third quarter of 2026 compared to the second quarter of 2026 at the Company's retail launch partner, underscoring growing consumer takeaway of Pinnacle® VLN® products.
  • Recently announced a distribution partnership with GoPuff, a direct-to-consumer digital convenience platform, expanding Pinnacle® VLN® distribution beyond traditional brick-and-mortar retail and adding significant consumer awareness options for adult smokers.
  • Expanded the Pinnacle Pure™ lineup to six total SKUs, including Yellow, Blue and Green (menthol) styles in both King Size and 100's, providing adult smokers with a broader range of flavor and format options.
  • Secured state regulatory approvals in an additional 13 states for the sale of Pinnacle® branded products, further expanding the Company's approved geographic footprint and supporting its continued retail distribution growth.
  • Shipped Pinnacle® VLN® into approximately 150 additional stores across metro New York and northern New Jersey, strengthening the Company's presence in one of the nation's largest convenience retail markets.

Third Quarter 2026 Product Line Net Revenues

  • Cigarette net revenues were $3.9 million, increased from $2.3 million in the second quarter of 2026 on higher cartons sold and improved pricing, reflecting a strategic shift away from high volume and low priced CMO export customers and toward higher margin natural style products, which is expected to accelerate revenue and margin growth in this category.
  • Filtered cigar net revenues were $0.7 million, compared to $0.7 million in the second quarter of 2026.
  • Distribution net revenues from other tobacco products were $0.1 million, compared to $(0.2) million in the second quarter of 2026, which reflected a one-time charge for the reversal and write-off of aged inventory discontinued by one of our customers.
  • VLN® cigarette net revenues were $0.03 million, compared to $0.03 million in the second quarter of 2026, reflecting consistent initial order and reorder activity primarily for our Pinnacle® VLN® products, offset by current period price promotions targeting expanded awareness, consumer trial and adoption.

Conference Call

22nd Century will host a live webcast today at 8:00 a.m. E.T. to discuss its third quarter 2026 financial results and business highlights. The live and archived webcast will be accessible in the Events section on 22nd Century’s Investor Relations website at https://ir.xxiicentury.com/events.


Summary Financial Results

(dollars in thousands, except per share data)

  Three Months Ended
  September 30,  Change
  2026  2025  $%
Revenues, net $4,759  $4,011  74818.6 
Gross loss $446  $(1,059) 1,505(142.1)
Operating loss $(2,578) $(3,212) 634(19.7)
Net loss from continuing operations $(2,565) $(3,763) 1,198(31.8)
Basic and diluted loss per common share from continuing operations $(3.92) $(313.79) 309.87(98.8)
Adjusted EBITDA (a) $(2,206) $(2,886) 68023.6 


  Nine Months Ended
  September 30,  Change
  2026  2025  $%
Revenues, net $11,729  $14,050  (2,321)(16.5)
Gross loss $(481) $(2,303) 1,822 (79.1)
Operating loss $(8,906) $(8,763) (143)1.6 
Net loss from continuing operations $(8,849) $(10,333) 1,484 (14.4)
Basic and diluted loss per common share from continuing operations $(29.47) $(2,290.62) 2,261.15 (98.7)
Adjusted EBITDA (a) $(8,302) $(7,844) (458)(5.8)

(a) Adjusted EBITDA is a non-GAAP financial measure. Please see “Notes Regarding Non-GAAP Financial Information” for additional information regarding our use of non-GAAP financial measures. Refer to Tables A at the end of this release for reconciliations of adjusted amounts to the closest corresponding GAAP financial measures.


Summary Product Line Results

(in thousands)

  Three Months Ended
  September 30,    
  2026 2025 Change
  $Cartons $Cartons $Cartons
Contract manufacturing         
Cigarettes 3,930131 2,520345 1,410 (214)
Filtered cigars 67480 1,282168 (608)(88)
Other tobacco products 12312 -- 123 12 
Total contract manufacturing 4,727223 3,802513 925 (290)
VLN® 321 2094 (177)(3)
Total product line revenues 4,759224 4,011517 748 (293)


  Nine Months Ended
  September 30,    
  2026 2025 Change
  $Cartons $Cartons $Cartons
Contract manufacturing         
Cigarettes 9,073342 10,2491,370 (1,176)(1,028)
Filtered cigars 2,240281 3,704498 (1,464)(217)
Other tobacco products 36127 8814 273 13 
Total contract manufacturing 11,674650 14,0411,882 (2,367)(1,232)
VLN® 551 91 46 - 
Total product line revenues 11,729651 14,0501,883 (2,321)(1,232)


About 22nd Century Group, Inc.

22nd Century Group is pioneering the tobacco harm reduction movement by enabling smokers to take control of their nicotine consumption.

Our Technology is Tobacco

Our proprietary non-GMO reduced nicotine tobacco plants were developed using our patented technologies that regulate alkaloid biosynthesis activities resulting in a tobacco plant that contains 95% less nicotine than traditional tobacco plants. Our extensive patent portfolio has been developed to ensure that our high-quality tobacco can be grown commercially at scale. We continue to develop our intellectual property to ensure our ongoing leadership in the tobacco harm reduction movement.

Our Products

We created our flagship product, the VLN® cigarette using our low nicotine tobacco, to give traditional cigarette smokers an authentic and familiar alternative in the form of a combustible cigarette that helps them take control of their nicotine consumption.

VLN® cigarettes have 95% less nicotine compared to traditional cigarettes and have been proven to allow consumers to greatly reduce their nicotine consumption.

FDA Authorization and Scientific Foundation

VLN® low nicotine combustible cigarettes were authorized in December 2021, making them the first and still the only combustible cigarettes authorized by the U.S. Food and Drug Administration specifically to help reduce nicotine consumption.

Decades of independent clinical research and peer-reviewed studies—evaluated as part of the FDA’s Modified Risk Tobacco Product (MRTP) authorization process—demonstrated that reducing nicotine content can decrease nicotine intake, increase quit attempts, and reduce overall exposure to nicotine.

FDA-authorized VLN® claims include:

  • “95% less nicotine”
  • “Helps reduce your nicotine consumption”
  • “Greatly reduces your nicotine consumption”
  • “Helps you smoke less”

VLN® and Helps You Smoke Less® are registered trademarks of 22nd Century Limited LLC.

Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.

Learn more about VLN® at tryvln.com and pinnaclevln.com.

Cautionary Note Regarding Forward-Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, and (iii) our financial and operating performance. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 26, 2026 and Quarterly Report on Form 10-Q filed on May 7, 2026, August 14, 2026 and November 16, 2026. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

Notes regarding Non-GAAP Financial Information

In addition to the Company’s reported results in accordance with generally accepted accounting principles in the United States of America (“GAAP”), the Company provides EBITDA and Adjusted EBITDA.

In order to calculate EBITDA, the Company adjusts net (loss) income by adding back interest expense (income), provision (benefit) for income taxes, and depreciation and amortization expense. Adjusted EBITDA consists of EBITDA adjusted by the Company for certain non-cash and/or non-operating expenses, including adding back equity-based employee compensation expense, restructuring and restructuring-related charges such as impairment, acquisition and transaction costs, and other unusual or infrequently occurring items, if applicable, such as inventory reserves and adjustments, master settlement agreement non-participating manufacturer settlement credits, gains or losses on disposal of property, plant and equipment, and gains or losses on investments.

The Company believes that the presentation of EBITDA and Adjusted EBITDA are important financial measures that supplement discussion and analysis of its financial condition and results of operations and enhances an understanding of its operating performance. While management considers EBITDA and Adjusted EBITDA to be important, these financial performance measures should be considered in addition to, but not as a substitute for or superior to, other measures of financial performance prepared in accordance with GAAP, such as operating (loss) income, net (loss) income and cash flows from operations. Adjusted EBITDA is susceptible to varying calculations and the Company’s measurement of Adjusted EBITDA may not be comparable to those of other companies.

Investor Relations & Media Contact
Daniel Otto
Chief Financial Officer & Investor Relations
22nd Century Group
investorrelations@xxiicentury.com

22nd CENTURY GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(amounts in thousands, except share and per-share data)

  September 30,  December 31, 
  2026  2025 
ASSETS      
Current assets:      
Cash and cash equivalents $3,911  $7,149 
Accounts receivable, net  4,109   3,594 
Inventories  4,357   4,326 
Prepaid expenses and other current assets  1,887   2,562 
Total current assets  14,264   17,631 
Property, plant and equipment, net  2,808   2,440 
Operating lease right-of-use assets, net  605   728 
Intangible assets, net  5,638   6,224 
Other assets  42   — 
Total assets $23,357  $27,023 
       
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS' EQUITY      
Current liabilities:      
Notes and loans payable-current $405  $204 
Operating lease obligations  180   168 
Accounts payable  821   1,000 
Accrued expenses and other current liabilities  789   836 
Accrued excise taxes and fees  3,058   3,343 
Contract liabilities  1,037   1,721 
Total current liabilities  6,290   7,272 
Long-term liabilities:      
Notes and loans payable  416   504 
Operating lease obligations  464   601 
Other long-term liabilities  111   154 
Total liabilities  7,281   8,531 
       
Mezzanine equity:      
Series A convertible preferred shares, $0.00001 par value; 10,000,000 shares authorized, 0 shares issued and outstanding at September 30, 2026 and 9,650 at December 31, 2025, respectively  —   2,734 
Total mezzanine equity  —   2,734 
       
Shareholders' equity:      
Series B convertible preferred shares, $0.00001 par value; 10,000,000 shares authorized, 8,505 shares issued and outstanding at September 30, 2026 and 0 at December 31, 2025, respectively  —   — 
Common stock, $.00001 par value, 500,000,000 shares authorized, 20,032 shares issued and outstanding at September 30, 2026 and 391 at December 31, 2025, respectively  —   — 
Capital in excess of par value  424,402   414,683 
Accumulated deficit  (408,326)  (398,925)
Total shareholders' equity  16,076   15,758 
Total liabilities, mezzanine equity and shareholders’ equity $23,357  $27,023 


22nd CENTURY GROUP, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
(amounts in thousands, except share and per-share data)

  Three Months Ended Nine Months Ended
  September 30,  September 30, 
  2026  2025  2026  2025 
Revenues, net $4,759  $4,011  $11,729  $14,050 
Cost of goods sold  1,655   2,557   5,201   8,304 
Excise taxes and fees on products  2,658   2,513   7,009   8,049 
Gross profit (loss)  446   (1,059)  (481)  (2,303)
Operating expenses:            
Sales, general and administrative  2,451   1,849   7,272   5,766 
Research and development  233   193   813   583 
Other operating expense, net  339   111   339   111 
Total operating expenses  3,023   2,153   8,424   6,460 
Operating loss from continuing operations  (2,577)  (3,212)  (8,905)  (8,763)
Other income (expense):            
Other expense  —   (33)  —   (207)
Interest income  30   16   104   46 
Interest expense  (17)  (534)  (47)  (1,443)
Total other income (expense), net  13   (551)  57   (1,604)
Loss from continuing operations before income taxes  (2,564)  (3,763)  (8,848)  (10,367)
(Benefit) provision for income taxes  —   —   —   (34)
Net loss from continuing operations $(2,564) $(3,763) $(8,848) $(10,333)
             
Discontinued operations:            
(Loss) income from discontinued operations before income taxes $(229) $9,252  $(552) $8,087 
Provision for income taxes  —   —   —   — 
Net (loss) income from discontinued operations $(229) $9,252  $(552) $8,087 
             
Net (loss) income $(2,793) $5,489  $(9,400) $(2,246)
Comprehensive (loss) income $(2,793) $5,489  $(9,400) $(2,246)
             
Net (loss) income $(2,793) $5,489  $(9,400) $(2,246)
Deemed dividends  —   —   (18,134)  — 
Dividend for redemption of Series A Convertible Preferred Stock  —   —   (6,916)  — 
Dividend for redemption of Series B Convertible Preferred Stock  —   —   (870)  — 
Net (loss) income available to common shareholders $(2,793) $5,489  $(35,320) $(2,246)
             
Basic and diluted loss per share:            
Basic and diluted loss per common share from continuing operations $(227.49) $(19,701.57) $(1,719.39) $(147,614.29)
Basic and diluted (loss) income per common share from discontinued operations $(20.32) $48,439.79  $(107.27) $115,528.57 
Basic and diluted (loss) income available to common shareholders per common share $(247.80) $28,738.22  $(6,863.58) $(32,085.71)
             
Weighted average shares outstanding - basic and diluted  11,271   191   5,146   70 


Table A – Reconciliations of Non-GAAP Measures

(dollars in thousands, except share and per-share data)

Below is a table containing information relating to the Company’s Net loss, EBITDA and Adjusted EBITDA for the three and nine months ended September 30, 2026 and 2025, including a reconciliation of these Non-GAAP measures for such periods.

  Three Months Ended
  September 30, 
  Amounts in thousands ($000's)
  except share and per share data
  (UNAUDITED)
         $ Change 
  2026  2025   fav / (unfav)1
Net loss from continuing operations $ (2,564) $ (3,763) $ 1,199 
Interest (income)/expense, net  (13)  518   (531)
Provision (benefit) for income taxes  —   —   — 
Amortization and depreciation  207   234   (27)
EBITDA $ (2,370) $ (3,011) $ 641 
Adjustments:         
Change in fair value of warrant liabilities  —   33   (33)
Excise taxes and fees on products - MSA NPM settlement credits  (550)  —   (550)
Impairment of intangible assets  339   —   339 
Equity-based employee compensation expense  375   92   283 
Adjusted EBITDA $ (2,206) $ (2,886) $ 680 
          
Adjusted EBITDA loss per common share $(195.70) $(15,146.14) $14,950.44 
Weighted average common shares outstanding - basic and diluted  11,271   191    


  Nine Months Ended
  September 30, 
  Amounts in thousands ($000's)
  except share and per share data
  (UNAUDITED)
         $ Change 
  2026  2025   fav / (unfav)1
Net loss from continuing operations $ (8,848) $ (10,333) $ 1,485 
Interest (income)/expense, net  (58)  1,397   (1,455)
Provision (benefit) for income taxes  —   (34)  34 
Amortization and depreciation  623   694   (71)
EBITDA $ (8,283) $ (8,276) $ (7)
Adjustments:         
Change in fair value of warrant liabilities  —   207   (207)
Excise taxes and fees on products - MSA NPM settlement credits  (1,242)  —   (1,242)
Impairment of intangible assets  339   —   339 
Equity-based employee compensation expense  886   225   661 
Adjusted EBITDA $ (8,300) $ (7,844) $ (456)
          
Adjusted EBITDA loss per common share $(1,612.99) $(112,263.68) $110,650.69 
Weighted average common shares outstanding - basic and diluted  5,146   70    


1
Fav = Favorable variance, which increases EBITDA and Adjusted EBITDA; Unfav = unfavorable variance, which reduces EBITDA and Adjusted EBITDA


GlobeNewswire